Let's cross-link: diverse functions of the promiscuous cellular transglutaminase, factor XIII-A

J L Mitchell, N J Mutch (Corresponding Author)

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Factor (F)XIII is a tranglutaminase enzyme that catalyses the formation of ε-(γ-glutamyl)lysyl isopeptide bonds into protein substrates. The plasma form, FXIIIA2 B2 has an established function in hemostasis, where its primary substrate is fibrin. A deficiency in FXIII manifests as a severe bleeding diathesis underscoring its importance in this pathway. The cellular form of the enzyme, a homodimer of the A subunits, denoted FXIII-A, has not been studied in as extensive detail. FXIII-A was generally perceived to remain intracellular, due to the lack of a classical signal peptide for its release. In the last decade emerging evidence has revealed that this diverse transglutaminase can be externalised from cells, by an as yet unknown mechanism, and can cross-link extracellular substrates and participate in a number of diverse pathways. The FXIII-A gene (F13A1) is expressed in cells of bone marrow and mesenchymal lineage, notably megakaryocytes, monocytes/macrophages, dendritic cells, chrondrocytes, osteoblasts and preadipocytes. The biological processes that FXIII-A is coupled with reflect its expression in these cell types, such as wound healing, phagocytosis and bone and matrix remodelling. This review describes the mounting evidence that this cellular transglutaminase can be externalised, usually in response to stimuli, and participate in extracellular cross-linking reactions. A corollary of being involved in these biological pathways is the participation of FXIII-A in pathological processes. In conclusion, the functions of this transglutaminase extend far beyond its role in hemostasis and our understanding of this enzyme in terms of its secretion, regulation and substrates is in its infancy. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)19-30
Number of pages12
JournalJournal of Thrombosis and Haemostasis
Volume17
Issue number1
Early online date7 Jan 2019
DOIs
Publication statusPublished - Jan 2019

Fingerprint

Factor XIII
Transglutaminases
Hemostasis
Enzymes
Biological Phenomena
Bone Matrix
Megakaryocytes
Bone Remodeling
Disease Susceptibility
Cross Reactions
Pathologic Processes
Protein Sorting Signals
Fibrin
Osteoblasts
Phagocytosis
Bone Marrow Cells
Wound Healing
Dendritic Cells
Monocytes
Macrophages

Keywords

  • Factor XIII
  • cross-link
  • transglutaminases
  • F13A1
  • cellular
  • factor XIII

ASJC Scopus subject areas

  • Hematology

Cite this

Let's cross-link : diverse functions of the promiscuous cellular transglutaminase, factor XIII-A. / Mitchell, J L; Mutch, N J (Corresponding Author).

In: Journal of Thrombosis and Haemostasis, Vol. 17, No. 1, 01.2019, p. 19-30.

Research output: Contribution to journalReview article

@article{1a67452abfe8474188b68a9538475075,
title = "Let's cross-link: diverse functions of the promiscuous cellular transglutaminase, factor XIII-A",
abstract = "Factor (F)XIII is a tranglutaminase enzyme that catalyses the formation of ε-(γ-glutamyl)lysyl isopeptide bonds into protein substrates. The plasma form, FXIIIA2 B2 has an established function in hemostasis, where its primary substrate is fibrin. A deficiency in FXIII manifests as a severe bleeding diathesis underscoring its importance in this pathway. The cellular form of the enzyme, a homodimer of the A subunits, denoted FXIII-A, has not been studied in as extensive detail. FXIII-A was generally perceived to remain intracellular, due to the lack of a classical signal peptide for its release. In the last decade emerging evidence has revealed that this diverse transglutaminase can be externalised from cells, by an as yet unknown mechanism, and can cross-link extracellular substrates and participate in a number of diverse pathways. The FXIII-A gene (F13A1) is expressed in cells of bone marrow and mesenchymal lineage, notably megakaryocytes, monocytes/macrophages, dendritic cells, chrondrocytes, osteoblasts and preadipocytes. The biological processes that FXIII-A is coupled with reflect its expression in these cell types, such as wound healing, phagocytosis and bone and matrix remodelling. This review describes the mounting evidence that this cellular transglutaminase can be externalised, usually in response to stimuli, and participate in extracellular cross-linking reactions. A corollary of being involved in these biological pathways is the participation of FXIII-A in pathological processes. In conclusion, the functions of this transglutaminase extend far beyond its role in hemostasis and our understanding of this enzyme in terms of its secretion, regulation and substrates is in its infancy. This article is protected by copyright. All rights reserved.",
keywords = "Factor XIII, cross-link, transglutaminases, F13A1, cellular, factor XIII",
author = "Mitchell, {J L} and Mutch, {N J}",
note = "This article is protected by copyright. All rights reserved.",
year = "2019",
month = "1",
doi = "10.1111/jth.14348",
language = "English",
volume = "17",
pages = "19--30",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Let's cross-link

T2 - diverse functions of the promiscuous cellular transglutaminase, factor XIII-A

AU - Mitchell, J L

AU - Mutch, N J

N1 - This article is protected by copyright. All rights reserved.

PY - 2019/1

Y1 - 2019/1

N2 - Factor (F)XIII is a tranglutaminase enzyme that catalyses the formation of ε-(γ-glutamyl)lysyl isopeptide bonds into protein substrates. The plasma form, FXIIIA2 B2 has an established function in hemostasis, where its primary substrate is fibrin. A deficiency in FXIII manifests as a severe bleeding diathesis underscoring its importance in this pathway. The cellular form of the enzyme, a homodimer of the A subunits, denoted FXIII-A, has not been studied in as extensive detail. FXIII-A was generally perceived to remain intracellular, due to the lack of a classical signal peptide for its release. In the last decade emerging evidence has revealed that this diverse transglutaminase can be externalised from cells, by an as yet unknown mechanism, and can cross-link extracellular substrates and participate in a number of diverse pathways. The FXIII-A gene (F13A1) is expressed in cells of bone marrow and mesenchymal lineage, notably megakaryocytes, monocytes/macrophages, dendritic cells, chrondrocytes, osteoblasts and preadipocytes. The biological processes that FXIII-A is coupled with reflect its expression in these cell types, such as wound healing, phagocytosis and bone and matrix remodelling. This review describes the mounting evidence that this cellular transglutaminase can be externalised, usually in response to stimuli, and participate in extracellular cross-linking reactions. A corollary of being involved in these biological pathways is the participation of FXIII-A in pathological processes. In conclusion, the functions of this transglutaminase extend far beyond its role in hemostasis and our understanding of this enzyme in terms of its secretion, regulation and substrates is in its infancy. This article is protected by copyright. All rights reserved.

AB - Factor (F)XIII is a tranglutaminase enzyme that catalyses the formation of ε-(γ-glutamyl)lysyl isopeptide bonds into protein substrates. The plasma form, FXIIIA2 B2 has an established function in hemostasis, where its primary substrate is fibrin. A deficiency in FXIII manifests as a severe bleeding diathesis underscoring its importance in this pathway. The cellular form of the enzyme, a homodimer of the A subunits, denoted FXIII-A, has not been studied in as extensive detail. FXIII-A was generally perceived to remain intracellular, due to the lack of a classical signal peptide for its release. In the last decade emerging evidence has revealed that this diverse transglutaminase can be externalised from cells, by an as yet unknown mechanism, and can cross-link extracellular substrates and participate in a number of diverse pathways. The FXIII-A gene (F13A1) is expressed in cells of bone marrow and mesenchymal lineage, notably megakaryocytes, monocytes/macrophages, dendritic cells, chrondrocytes, osteoblasts and preadipocytes. The biological processes that FXIII-A is coupled with reflect its expression in these cell types, such as wound healing, phagocytosis and bone and matrix remodelling. This review describes the mounting evidence that this cellular transglutaminase can be externalised, usually in response to stimuli, and participate in extracellular cross-linking reactions. A corollary of being involved in these biological pathways is the participation of FXIII-A in pathological processes. In conclusion, the functions of this transglutaminase extend far beyond its role in hemostasis and our understanding of this enzyme in terms of its secretion, regulation and substrates is in its infancy. This article is protected by copyright. All rights reserved.

KW - Factor XIII

KW - cross-link

KW - transglutaminases

KW - F13A1

KW - cellular

KW - factor XIII

UR - http://www.scopus.com/inward/record.url?scp=85059495577&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/lets-crosslink-diverse-functions-promiscuous-cellular-transglutaminase-factorxiiia

U2 - 10.1111/jth.14348

DO - 10.1111/jth.14348

M3 - Review article

C2 - 30489000

VL - 17

SP - 19

EP - 30

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 1

ER -